<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">54363</article-id><article-id pub-id-type="doi">10.7554/eLife.54363</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-170515"><name><surname>McGregor</surname><given-names>Tracy L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-170516"><name><surname>Hunt</surname><given-names>Karen A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170517"><name><surname>Yee</surname><given-names>Elaine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-170518"><name><surname>Mason</surname><given-names>Dan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170519"><name><surname>Nioi</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-170520"><name><surname>Ticau</surname><given-names>Simina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-170527"><name><surname>Pelosi</surname><given-names>Marissa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-170528"><name><surname>Loken</surname><given-names>Perry R</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170529"><name><surname>Finer</surname><given-names>Sarah</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2684-4653</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81201"><name><surname>Lawlor</surname><given-names>Deborah A</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170530"><name><surname>Fauman</surname><given-names>Eric B</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-177887"><name><surname>Huang</surname><given-names>Qin Qin</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170531"><name><surname>Griffiths</surname><given-names>Christopher J</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170532"><name><surname>MacArthur</surname><given-names>Daniel G</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170533"><name><surname>Trembath</surname><given-names>Richard C</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170534"><name><surname>Oglesbee</surname><given-names>Devin</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-162571"><name><surname>Lieske</surname><given-names>John C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0202-5944</contrib-id><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170535"><name><surname>Erbe</surname><given-names>David V</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-170537"><name><surname>Wright</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-167994"><name><surname>van Heel</surname><given-names>David A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0637-2265</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Clinical Research</institution>, <institution>Alnylam Pharmaceuticals</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Blizard Institute</institution>, <institution>Queen Mary University of London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Bradford Institute for Health Research</institution>, <institution>Bradford Teaching Hospitals NHS Foundation Trust</institution>, <addr-line><named-content content-type="city">Bradford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Division of Nephrology and Hypertension</institution>, <institution>Mayo Clinic</institution>, <addr-line><named-content content-type="city">Rochester</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Institute of Population and Health Science</institution>, <institution>Queen Mary University of London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff6"><institution>University of Bristol</institution>, <addr-line><named-content content-type="city">Bristol</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff7"><institution content-type="dept">Internal Medicine Research Unit</institution>, <institution>Pfizer Worldwide Research</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Medical and Population Genomics</institution>, <institution>Wellcome Sanger Institute</institution>, <addr-line><named-content content-type="city">Hinxton</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff9"><institution content-type="dept">Program in Medical and Population Genetics</institution>, <institution>Broad Institute of MIT and Harvard</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff10"><institution content-type="dept">Faculty of Life Sciences and Medicine</institution>, <institution>Kings College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff11"><institution content-type="dept">Nehrology and Hypertension</institution>, <institution>Mayo Clinic</institution>, <addr-line><named-content content-type="city">Rochester</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-66036"><name><surname>Goate</surname><given-names>Alison</given-names></name><role>Reviewing editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>d.vanheel@qmul.ac.uk</email> (Dv);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>03</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e54363</elocation-id><history><date date-type="received"><day>11</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>23</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, McGregor et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>McGregor et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-54363-v1.pdf"/><abstract><p>By sequencing autozygous human populations we identified a healthy adult woman with lifelong complete knockout of <italic>HAO1</italic> (expected ~1 in 30 million outbred people). <italic>HAO1</italic> (glycolate oxidase) silencing is the mechanism of lumasiran, an investigational RNA interference therapeutic for primary hyperoxaluria type 1. Her plasma glycolate levels were 12 times, and urinary glycolate 6 times, the upper limit of normal observed in healthy reference individuals (n=67). Plasma metabolomics and lipidomics (1871 biochemicals) revealed 18 markedly elevated biochemicals (&gt;5sd outliers versus n=25 controls) suggesting additional HAO1 effects. Comparison with lumasiran preclinical and clinical trial data suggested she has &lt;2% residual glycolate oxidase activity. Cell line p.Leu333SerfsTer4 expression showed markedly reduced HAO1 protein levels and cellular protein mis-localisation. In this woman, lifelong <italic>HAO1</italic> knockout is safe and without clinical phenotype, de-risking a therapeutic approach and informing therapeutic mechanisms. Unlocking evidence from the diversity of human genetic variation can facilitate drug development.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT102627</award-id><principal-award-recipient><name><surname>van Heel</surname><given-names>David A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT210561</award-id><principal-award-recipient><name><surname>van Heel</surname><given-names>David A</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>M009017</award-id><principal-award-recipient><name><surname>van Heel</surname><given-names>David A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Tracy L McGregor, employee of Alnylam Pharmaceuticals.</p></fn><fn fn-type="conflict" id="conf3"><p>Elaine Yee, employee of Alnylam Pharmaceuticals.</p></fn><fn fn-type="conflict" id="conf4"><p>Paul Nioi, employee of Alnylam Pharmaceuticals.</p></fn><fn fn-type="conflict" id="conf5"><p>Simina Ticau, employee of Alnylam Pharmaceuticals.</p></fn><fn fn-type="conflict" id="conf6"><p>Marissa Pelosi, employee of Alnylam Pharmaceuticals.</p></fn><fn fn-type="conflict" id="conf7"><p>Eric B Fauman, Eric B. Fauman is affiliated with Pfizer Worldwide Research. The author has no financial interests to declare. Eric B. Fauman contributed as an individual and the work was not part of a Pfizer collaboration nor was it funded by Pfizer..</p></fn><fn fn-type="conflict" id="conf8"><p>David V Erbe, employee of Alnylam Pharmaceuticals.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The HAO1 knockout volunteer took part in both the Born In Bradford study and the Genes &amp; Health study. Volunteers providing control samples took part in the Genes &amp; Health study. Ethical approval was obtained from Bradford National Research Ethics Committee (06/Q1202/48) and the South East London National Research Ethics Committee (14/LO/1240). Informed consent and consent to publish was obtained.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All metabolomic data is available in full in the Supplementary Files.</p></sec><supplementary-material><ext-link xlink:href="elife-54363-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>